Clinical Trial VICCHEM1137
Title
MicroRNAs in Myelodysplastic Syndrome
Principal Investigator(s)
Details
- Protocol No. VICCHEM1137
- Open Date: 07/22/2011
- Staging: NA
- Age Group: Adults
- Scope: National
- Objective: Determine the contribution of hypermethylation in the dysregulation of miRNA expression in MDS.
- Disease Sites:
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Boston Baskin Cancer Group (UTCI); Thomas Jefferson University Hospital; Jackson-Madison County Hospital; Roswell Park Cancer Institute; The Jones Clinic; Vanderbilt University
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
